{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T15:40:25Z","timestamp":1791560425139,"version":"4.3.4"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2024,5,16]],"date-time":"2024-05-16T00:00:00Z","timestamp":1715817600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,5,16]],"date-time":"2024-05-16T00:00:00Z","timestamp":1715817600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Acta Parasit."],"published-print":{"date-parts":[[2024,6]]},"DOI":"10.1007\/s11686-024-00852-9","type":"journal-article","created":{"date-parts":[[2024,5,16]],"date-time":"2024-05-16T14:02:06Z","timestamp":1715868126000},"page":"1275-1283","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["In Vitro Evaluation of Anti-Parasitic Activities of Quinolone-Coumarin Hybrids Derived from Fluoroquinolones and Novobiocin Against Toxoplasma gondii"],"prefix":"10.1007","volume":"69","author":[{"given":"Saeed","family":"Emami","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mitra","family":"Sadeghi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shayesteh","family":"Shahdin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmad","family":"Daryani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alireza","family":"Khalilian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Majid","family":"Pirestani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seyed Abdollah","family":"Hosseini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahboobeh","family":"Montazeri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zahra Hosseini","family":"Nejad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shahabeddin","family":"Sarvi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,5,16]]},"reference":[{"issue":"4","key":"852_CR1","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1016\/j.exppara.2013.10.001","volume":"135","author":"W Chemoh","year":"2013","unstructured":"Chemoh W, Sawangjaroen N, Nissapatorn V, Suwanrath C, Chandeying V, Hortiwakul T et al (2013) Toxoplasma gondii infection: what is the real situation? Exp Parasitol 135(4):685\u2013689. https:\/\/doi.org\/10.1016\/j.exppara.2013.10.001","journal-title":"Exp Parasitol"},{"key":"852_CR2","unstructured":"Weiss LM (2013) Toxoplasma gondii: the Model Apicomplexan-perspectives and methods Ed, vol 2. Elsevier Science"},{"issue":"3","key":"852_CR3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.26717\/BJSTR.2019.15.002698","volume":"15","author":"AL Pani\u00e1gua","year":"2019","unstructured":"Pani\u00e1gua AL, Almeida RM, Leite FB, da Silva AC, Santos IJ, Moreira EE et al (2019) Toxoplasmosis in pregnant women: prevalence in one University Hospital (Bras\u00edlia City, Distrito Federal, Brazil). Biomed J Sci Tech Res 15(3):1\u20132. https:\/\/doi.org\/10.26717\/BJSTR.2019.15.002698","journal-title":"Biomed J Sci Tech Res"},{"issue":"12","key":"852_CR4","doi-asserted-by":"publisher","first-page":"1385","DOI":"10.1016\/j.ijpara.2009.04.003","volume":"39","author":"G Pappas","year":"2009","unstructured":"Pappas G, Roussos N, Falagas ME (2009) Toxoplasmosis snapshots: global status of Toxoplasma gondii seroprevalence and implications for pregnancy and congenital toxoplasmosis. Int J Parasitol 39(12):1385\u20131394. https:\/\/doi.org\/10.1016\/j.ijpara.2009.04.003","journal-title":"Int J Parasitol"},{"issue":"6","key":"852_CR5","doi-asserted-by":"publisher","first-page":"e0004790","DOI":"10.1371\/journal.pntd.0004790","volume":"10","author":"D Ajzenberg","year":"2016","unstructured":"Ajzenberg D, Lamaury I, Demar M, Vautrin C, Cabi\u00e9 A, Simon S et al (2016) Performance testing of PCR assay in blood samples for the diagnosis of toxoplasmic encephalitis in AIDS patients from the French departments of America and genetic diversity of Toxoplasma gondii: a prospective and multicentric study. PLoS Negl Trop Dis 10(6):e0004790. https:\/\/doi.org\/10.1371\/journal.pntd.0004790","journal-title":"PLoS Negl Trop Dis"},{"key":"852_CR6","unstructured":"Weiss LM (2013) Toxoplasma gondii: The Model Apicomplexan-Perspectives and Methods Ed. 2. Perspectives and methods"},{"issue":"1","key":"852_CR7","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1093\/jac\/dkl180","volume":"58","author":"ES Martins-Duarte","year":"2006","unstructured":"Martins-Duarte ES, Urbina JA, de Souza W, Vommaro RC (2006) Antiproliferative activities of two novel quinuclidine inhibitors against Toxoplasma gondii tachyzoites in vitro. J Antimicrob Chemother 58(1):59\u201365. https:\/\/doi.org\/10.1093\/jac\/dkl180","journal-title":"J Antimicrob Chemother"},{"issue":"5","key":"852_CR8","first-page":"483","volume":"3","author":"D Eyles","year":"1953","unstructured":"Eyles D, Coleman N (1953) Synergistic effect of Sulfadiazlne and Daraprim against Experimental Toxoplasmosis in the mouse. Antibiot Chemother 3(5):483\u2013490","journal-title":"Antibiot Chemother"},{"issue":"1","key":"852_CR9","doi-asserted-by":"publisher","first-page":"14","DOI":"10.4269\/ajtmh.1973.22.14","volume":"22","author":"PR Mcmaster","year":"1973","unstructured":"Mcmaster PR, Powers KG, Finerty JF, Lunde MN (1973) The effect of two chlorinated lincomycin analogues against acute toxoplasmosis in mice. Am J Trop Med Hyg 22(1):14\u201317. https:\/\/doi.org\/10.4269\/ajtmh.1973.22.14","journal-title":"Am J Trop Med Hyg"},{"issue":"1","key":"852_CR10","doi-asserted-by":"publisher","first-page":"33","DOI":"10.7326\/0003-4819-116-1-33","volume":"116","author":"B Dannemann","year":"1992","unstructured":"Dannemann B, McCutchan JA, Israelski D, Antoniskis D, Leport C, Luft B et al (1992) Treatment of toxoplasmic encephalitis in patients with AIDS: a randomized trial comparing pyrimethamine plus clindamycin to pyrimethamine plus sulfadiazine. Ann Intern Med 116(1):33\u201343. https:\/\/doi.org\/10.7326\/0003-4819-116-1-33","journal-title":"Ann Intern Med"},{"issue":"1","key":"852_CR11","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S0002-9394(14)70986-9","volume":"123","author":"MB Mets","year":"1997","unstructured":"Mets MB, Holfels E, Boyer KM, Swisher CN, Roizen N, Stein L et al (1997) Eye manifestations of congenital toxoplasmosis. Am J Ophthalmol 123(1):1\u201316. https:\/\/doi.org\/10.1016\/S0002-9394(14)70986-9","journal-title":"Am J Ophthalmol"},{"key":"852_CR12","doi-asserted-by":"publisher","first-page":"179","DOI":"10.2165\/00003495-199448020-00005","volume":"48","author":"SV Georgiev","year":"1994","unstructured":"Georgiev SV (1994) Management of toxoplasmosis. Drugs 48:179\u2013188. https:\/\/doi.org\/10.2165\/00003495-199448020-00005","journal-title":"Drugs"},{"issue":"2","key":"852_CR13","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1093\/clinids\/15.2.211","volume":"15","author":"BJ Luft","year":"1992","unstructured":"Luft BJ, Remington JS (1992) Toxoplasmic encephalitis in AIDS. Clin Infect Dis 15(2):211\u2013222. https:\/\/doi.org\/10.1093\/clinids\/15.2.211","journal-title":"Clin Infect Dis"},{"key":"852_CR14","doi-asserted-by":"publisher","unstructured":"F. H (2008) Post-treatment assessment of acute Toxoplasma infection during pregnancy. J Obstet Gynaecol 28:593\u2013595. https:\/\/doi.org\/10.1080\/01443610802344332","DOI":"10.1080\/01443610802344332"},{"issue":"14","key":"852_CR15","doi-asserted-by":"publisher","first-page":"1515","DOI":"10.1016\/j.ijpara.2006.08.004","volume":"36","author":"E Del Cacho","year":"2006","unstructured":"Del Cacho E, Gallego M, Pages M, Monteagudo L, S\u00e1nchez-Acedo C (2006) Effect of the quinolone coccidiostat decoquinate on the rearrangement of chromosomes of Eimeria tenella. Int J Parasitol 36(14):1515\u20131520. https:\/\/doi.org\/10.1016\/j.ijpara.2006.08.004","journal-title":"Int J Parasitol"},{"key":"852_CR16","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1007\/s10534-013-9661-z","volume":"26","author":"LR Gouvea","year":"2013","unstructured":"Gouvea LR, Martins DA, da Gama Jean Batista D, de Nazar\u00e9 C, Soeiro M, Louro SR, Barbeira PJ et al (2013) Norfloxacin Zn (II)-based complexes: acid base ionization constant determination, DNA and albumin binding properties and the biological effect against Trypanosoma cruzi. Biometals 26:813\u2013825. DOI https:\/\/doi.org\/10.1007\/s10534-013-9661-z","journal-title":"Biometals"},{"issue":"Supplement1","key":"852_CR17","doi-asserted-by":"publisher","first-page":"S9","DOI":"10.1086\/319370","volume":"32","author":"DC Hooper","year":"2001","unstructured":"Hooper DC (2001) Mechanisms of action of antimicrobials: focus on fluoroquinolones. Clin Infect Dis 32(Supplement1):S9\u2013S15. https:\/\/doi.org\/10.1086\/319370","journal-title":"Clin Infect Dis"},{"key":"852_CR18","doi-asserted-by":"publisher","first-page":"705","DOI":"10.2165\/00002018-200730080-00007","volume":"30","author":"CB Johannes","year":"2007","unstructured":"Johannes CB, Ziyadeh N, Seeger JD, Tucker E, Reiter C, Faich G (2007) Incidence of allergic reactions associated with antibacterial use in a large, managed care organisation. Drug Saf 30:705\u2013713. https:\/\/doi.org\/10.2165\/00002018-200730080-00007","journal-title":"Drug Saf"},{"issue":"5","key":"852_CR19","doi-asserted-by":"publisher","first-page":"e0125705","DOI":"10.1371\/journal.pone.0125705","volume":"10","author":"ES Martins-Duarte","year":"2015","unstructured":"Martins-Duarte ES, Dubar F, Lawton P, Fran\u00e7a da Silva C, Soeiro MdN C, De Souza W et al (2015) Ciprofloxacin derivatives affect parasite cell division and increase the survival of mice infected with Toxoplasma gondii. PLoS ONE 10(5):e0125705. https:\/\/doi.org\/10.1371\/journal.pone.0125705","journal-title":"PLoS ONE"},{"issue":"1","key":"852_CR20","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1002\/ardp.200700090","volume":"341","author":"S Emami","year":"2008","unstructured":"Emami S, Foroumadi A, Faramarzi MA, Samadi N (2008) Synthesis and antibacterial activity of Quinolone-based compounds containing a Coumarin Moiety. Archiv Der Pharmazie: Int J Pharm Med Chem 341(1):42\u201348. https:\/\/doi.org\/10.1002\/ardp.200700090","journal-title":"Archiv Der Pharmazie: Int J Pharm Med Chem"},{"key":"852_CR21","doi-asserted-by":"publisher","unstructured":"Akins CK, Panicker SE, Cunningham CL (2005) Laboratory animals in research and teaching: Ethics, care, and methods: American Psychological Association. https:\/\/doi.org\/10.1037\/10830-000","DOI":"10.1037\/10830-000"},{"issue":"1\u20132","key":"852_CR22","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.vetpar.2011.12.039","volume":"187","author":"BF Barbosa","year":"2012","unstructured":"Barbosa BF, Gomes AO, Ferro EAV, Napolitano DR, Mineo JR, Silva NM (2012) Enrofloxacin is able to control Toxoplasma gondii infection in both in vitro and in vivo experimental models. Vet Parasitol 187(1\u20132):44\u201352. https:\/\/doi.org\/10.1016\/j.vetpar.2011.12.039","journal-title":"Vet Parasitol"},{"issue":"10","key":"852_CR23","doi-asserted-by":"publisher","first-page":"2771","DOI":"10.1128\/aac.44.10.2771-2776.2000","volume":"44","author":"R Gozalbes","year":"2000","unstructured":"Gozalbes R, Brun-Pascaud M, Garcia-Domenech R, Galvez J, Girard P-M, Doucet J-P et al (2000) Anti-Toxoplasma activities of 24 quinolones and fluoroquinolones in vitro: prediction of activity by molecular topology and virtual computational techniques. Antimicrob Agents Chemother 44(10):2771\u20132776. https:\/\/doi.org\/10.1128\/aac.44.10.2771-2776.2000","journal-title":"Antimicrob Agents Chemother"},{"key":"852_CR24","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1016\/j.actatropica.2016.12.006","volume":"167","author":"RA Sanfelice","year":"2017","unstructured":"Sanfelice RA, da Silva SS, Bosqui LR, Miranda-Sapla MM, Barbosa BF, Silva RJ et al (2017) Pravastatin and simvastatin inhibit the adhesion, replication and proliferation of Toxoplasma gondii (RH strain) in HeLa cells. Acta Trop 167:208\u2013215. https:\/\/doi.org\/10.1016\/j.actatropica.2016.12.006","journal-title":"Acta Trop"},{"issue":"7","key":"852_CR25","doi-asserted-by":"publisher","first-page":"1783","DOI":"10.1128\/aac.43.7.1783","volume":"43","author":"AA Khan","year":"1999","unstructured":"Khan AA, Araujo FG, Brighty KE, Gootz TD, Remington JS (1999) Anti-Toxoplasma gondii activities and structure-activity relationships of novel fluoroquinolones related to trovafloxacin. Antimicrob Agents Chemother 43(7):1783\u20131787. https:\/\/doi.org\/10.1128\/aac.43.7.1783","journal-title":"Antimicrob Agents Chemother"},{"issue":"3","key":"852_CR26","doi-asserted-by":"publisher","first-page":"220","DOI":"10.3831\/KPI.2017.20.026","volume":"20","author":"MA Ebrahimzadeh","year":"2017","unstructured":"Ebrahimzadeh MA, Taheri MM, Ahmadpour E, Montazeri M, Sarvi S, Akbari M et al (2017) Anti-Toxoplasma effects of methanol extracts of Feijoa sellowiana, quercus castaneifolia, and Allium paradoxum. J Pharmacopunct 20(3):220. https:\/\/doi.org\/10.3831\/KPI.2017.20.026","journal-title":"J Pharmacopunct"},{"issue":"1","key":"852_CR27","doi-asserted-by":"publisher","first-page":"A3B","DOI":"10.1002\/0471142735.ima03bs21","volume":"21","author":"W Strober","year":"1997","unstructured":"Strober W (1997) Trypan blue exclusion test of cell viability. Curr Protoc Immunol 21(1):A3B\u2013A31. https:\/\/doi.org\/10.1002\/0471142735.ima03bs21","journal-title":"Curr Protoc Immunol"},{"key":"852_CR28","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.exppara.2019.03.009","volume":"200","author":"M Montazeri","year":"2019","unstructured":"Montazeri M, Emami S, Asgarian-Omran H, Azizi S, Sharif M, Sarvi S et al (2019) In vitro and in vivo evaluation of kojic acid against Toxoplasma gondii in experimental models of acute toxoplasmosis. Exp Parasitol 200:7\u201312. https:\/\/doi.org\/10.1016\/j.exppara.2019.03.009","journal-title":"Exp Parasitol"},{"issue":"4","key":"852_CR29","doi-asserted-by":"publisher","first-page":"1269","DOI":"10.1128\/aac.01203-07","volume":"52","author":"P Meneceur","year":"2008","unstructured":"Meneceur P, Bouldouyre M-A, Aubert D, Villena I, Menotti J, Sauvage V et al (2008) In vitro susceptibility of various genotypic strains of Toxoplasma gondii to pyrimethamine, sulfadiazine, and atovaquone. Antimicrob Agents Chemother 52(4):1269\u20131277. https:\/\/doi.org\/10.1128\/aac.01203-07","journal-title":"Antimicrob Agents Chemother"},{"key":"852_CR30","doi-asserted-by":"publisher","unstructured":"Alday PH, Doggett JS (2017) Drugs in development for toxoplasmosis: advances, challenges, and current status. Drug design, development and therapy 273\u2013\u200993. https:\/\/doi.org\/10.2147\/DDDT.S60973","DOI":"10.2147\/DDDT.S60973"},{"key":"852_CR31","doi-asserted-by":"publisher","first-page":"25","DOI":"10.3389\/fmicb.2017.00025","volume":"8","author":"M Montazeri","year":"2017","unstructured":"Montazeri M, Sharif M, Sarvi S, Mehrzadi S, Ahmadpour E, Daryani A (2017) A systematic review of in vitro and in vivo activities of anti-Toxoplasma drugs and compounds (2006\u20132016). Front Microbiol 8:25. https:\/\/doi.org\/10.3389\/fmicb.2017.00025","journal-title":"Front Microbiol"},{"key":"852_CR32","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1007\/s00431-005-1665-4","volume":"165","author":"DR Schmidt","year":"2006","unstructured":"Schmidt DR, Hogh B, Andersen O, Hansen SH, Dalhoff K, Petersen E (2006) Treatment of infants with congenital toxoplasmosis: tolerability and plasma concentrations of sulfadiazine and pyrimethamine. Eur J Pediatr 165:19\u201325. https:\/\/doi.org\/10.1007\/s00431-005-1665-4","journal-title":"Eur J Pediatr"},{"issue":"6","key":"852_CR33","doi-asserted-by":"publisher","first-page":"620","DOI":"10.1016\/j.ijantimicag.2003.11.005","volume":"23","author":"L Dantas-Leite","year":"2004","unstructured":"Dantas-Leite L, Urbina JA, de Souza W, Vommaro RC (2004) Selective anti-Toxoplasma gondii activities of azasterols. Int J Antimicrob Agents 23(6):620\u2013626. https:\/\/doi.org\/10.1016\/j.ijantimicag.2003.11.005","journal-title":"Int J Antimicrob Agents"},{"issue":"1\u20132","key":"852_CR34","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/j.vetpar.2010.11.034","volume":"177","author":"\u00c9S Martins-Duarte","year":"2011","unstructured":"Martins-Duarte \u00c9S, Lemgruber L, Lorente SO, Gros L, Magaraci F, Gilbert IH et al (2011) Evaluation of three novel azasterols against Toxoplasma gondii. Vet Parasitol 177(1\u20132):157\u2013161. https:\/\/doi.org\/10.1016\/j.vetpar.2010.11.034","journal-title":"Vet Parasitol"},{"key":"852_CR35","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1007\/s00253-011-3557-z","volume":"92","author":"F Collin","year":"2011","unstructured":"Collin F, Karkare S, Maxwell A (2011) Exploiting bacterial DNA gyrase as a drug target: current state and perspectives. Appl Microbiol Biotechnol 92:479\u2013497. https:\/\/doi.org\/10.1007\/s00253-011-3557-z","journal-title":"Appl Microbiol Biotechnol"},{"key":"852_CR36","first-page":"1","volume":"5","author":"T-Y Lin","year":"2015","unstructured":"Lin T-Y, NS, Gardiner Heddle J (2015) Functional analyses of the Toxoplasma gondii DNA gyrase holoenzyme: a janus topoisomerase with supercoiling and decatenation abilities. Sci Rep 5:1\u201313","journal-title":"Sci Rep"},{"issue":"7","key":"852_CR37","doi-asserted-by":"publisher","first-page":"1574","DOI":"10.3390\/molecules25071574","volume":"25","author":"A Secrieru","year":"2020","unstructured":"Secrieru A, Costa IC, O\u2019Neill PM, Cristiano ML (2020) Antimalarial agents as therapeutic tools against toxoplasmosis\u2014a short bridge between two distant illnesses. Molecules 25(7):1574. https:\/\/doi.org\/10.3390\/molecules25071574","journal-title":"Molecules"},{"issue":"2","key":"852_CR38","first-page":"1","volume":"5","author":"K Rohini","year":"2014","unstructured":"Rohini K, Srikumar P (2014) Therapeutic role of coumarins and coumarin-related compounds. J Thermodyn Catal 5(2):1\u20133","journal-title":"J Thermodyn Catal"},{"issue":"10","key":"852_CR39","doi-asserted-by":"publisher","first-page":"e0164585","DOI":"10.1371\/journal.pone.0164585","volume":"11","author":"V Mandlik","year":"2016","unstructured":"Mandlik V, Patil S, Bopanna R, Basu S, Singh S (2016) Biological activity of coumarin derivatives as anti-leishmanial agents. PLoS ONE 11(10):e0164585. https:\/\/doi.org\/10.1371\/journal.pone.0164585","journal-title":"PLoS ONE"},{"key":"852_CR40","doi-asserted-by":"publisher","first-page":"100012","DOI":"10.1016\/j.ejmcr.2021.100012","volume":"3","author":"JO de Souza","year":"2021","unstructured":"de Souza JO, Almeida SM, Souza GE, Zanini CL, da Silva EM, Calit J et al (2021) Parasitological profiling shows 4 (1H)-quinolone derivatives as new lead candidates for malaria. Eur J Med Chem Rep 3:100012. https:\/\/doi.org\/10.1016\/j.ejmcr.2021.100012","journal-title":"Eur J Med Chem Rep"},{"issue":"3","key":"852_CR41","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1128\/aac.29.3.426","volume":"29","author":"P Pate","year":"1986","unstructured":"Pate P, Wolfson J, McHugh G, Pan S, Swartz M (1986) Novobiocin antagonism of amastigotes of Trypanosoma cruzi growing in cell-free medium. Antimicrob Agents Chemother 29(3):426\u2013431. https:\/\/doi.org\/10.1128\/aac.29.3.426","journal-title":"Antimicrob Agents Chemother"},{"key":"852_CR42","doi-asserted-by":"publisher","first-page":"340","DOI":"10.3389\/fcimb.2017.00340","volume":"7","author":"RJGA da Silva","year":"2017","unstructured":"da Silva RJGA, Franco PS, Pereira AS, Milian IC, Ribeiro M et al (2017) Enrofloxacin and toltrazuril are able to reduce Toxoplasma gondii growth in human BeWo trophoblastic cells and villous explants from human third trimester pregnancy. Front Cell Infect Microbiol 7:340. https:\/\/doi.org\/10.3389\/fcimb.2017.00340","journal-title":"Front Cell Infect Microbiol"}],"container-title":["Acta Parasitologica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11686-024-00852-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11686-024-00852-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11686-024-00852-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,17]],"date-time":"2024-06-17T08:21:13Z","timestamp":1718612473000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11686-024-00852-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5,16]]},"references-count":42,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2024,6]]}},"alternative-id":["852"],"URL":"https:\/\/doi.org\/10.1007\/s11686-024-00852-9","relation":{},"ISSN":["1230-2821","1896-1851"],"issn-type":[{"value":"1230-2821","type":"print"},{"value":"1896-1851","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,5,16]]},"assertion":[{"value":"5 November 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 April 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 May 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interest"}}]}}